FDA Clears Way for Clinical Trial of VOR33 Stem Cell Therapy
News
Vor Biopharma has been cleared in the U.S. to begin clinical trial testing of its investigational cell therapy, VOR33, for acute myeloid leukemia (AML). The U.S. Food and Drug ... Read more